Jay S. Duker insider trades

Open-market stock purchases and sales by Jay S. Duker, President and CEO at EyePoint, Inc, from SEC Form 4 filings since Jan 20, 2015.

Track record: 50% of 2 scored buys are up 5% or more since purchase, averaging +51%.

Recent trades

DateStockTradeValue
Jul 10, 2026EYPT EyePoint, IncSold (not open market)$119K
Jul 10, 2026EYPT EyePoint, IncBought (not open market)—
Mar 23, 2026EYPT EyePoint, IncBought (not open market)$1M
Mar 23, 2026EYPT EyePoint, IncBought (not open market)$459K
Mar 23, 2026EYPT EyePoint, IncBought (not open market)$933K
Mar 16, 2026EYPT EyePoint, IncBought$19.7K
Jan 6, 2026EYPT EyePoint, IncSold (not open market)$170K
Jan 6, 2026EYPT EyePoint, IncBought (not open market)—
Jan 5, 2026EYPT EyePoint, IncSold (not open market)$253K
Jan 5, 2026EYPT EyePoint, IncBought (not open market)—
Jan 3, 2026EYPT EyePoint, IncSold (not open market)$410K
Jan 3, 2026EYPT EyePoint, IncBought (not open market)—
Jan 2, 2026EYPT EyePoint, IncBought (not open market)—
Jan 2, 2026EYPT EyePoint, IncBought (not open market)—

Companies traded

  • EYPT EyePoint, Inc: 2 buys, last Jul 10, 2026
  • SESN Sesen Bio, Inc: other filings, last Jun 22, 2022
  • PSDV pSivida Corp: other filings, last Dec 15, 2017
  • EBIO Eleven Biotherapeutics, Inc: other filings, last May 19, 2017

Get free alerts when Jay S. Duker files a new trade →